Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

780 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).
Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ. Valgimigli M, et al. Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18. Am J Cardiol. 2014. PMID: 25129064 Clinical Trial.
Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance.
Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, Tsuchida K, McFadden EP, Ligthart JM, Smits PC, de Jaegere P, Sianos G, Van der Giessen WJ, De Feyter P, Serruys PW. Agostoni P, et al. Among authors: valgimigli m. Am J Cardiol. 2005 Mar 1;95(5):644-7. doi: 10.1016/j.amjcard.2004.10.042. Am J Cardiol. 2005. PMID: 15721110
Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH).
Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Valgimigli M, et al. Circulation. 2005 Mar 22;111(11):1383-9. doi: 10.1161/01.CIR.0000158486.20865.8B. Circulation. 2005. PMID: 15781749
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT. Ong AT, et al. Among authors: valgimigli m. J Am Coll Cardiol. 2005 Apr 5;45(7):1135-41. doi: 10.1016/j.jacc.2005.01.008. J Am Coll Cardiol. 2005. PMID: 15808774 Free article.
Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).
Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, Tsuchida K, Sonnenschein K, Regar E, van der Giessen WJ, de Jaegere PP, Sianos G, McFadden EP, de Feyter PJ, van Domburg RT, Serruys PW. Ong AT, et al. Among authors: valgimigli m. Am J Cardiol. 2005 Aug 1;96(3):358-62. doi: 10.1016/j.amjcard.2005.03.075. Am J Cardiol. 2005. PMID: 16054457
Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with paclitaxel-eluting stents.
Tsuchida K, Ong AT, Aoki J, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sianos G, Regar E, McFadden EP, van der Giessen WJ, de Feyter PJ, de Jaegere PP, van Domburg RT, Serruys PW. Tsuchida K, et al. Among authors: valgimigli m. Am J Cardiol. 2005 Aug 1;96(3):395-8. doi: 10.1016/j.amjcard.2005.03.084. Am J Cardiol. 2005. PMID: 16054466
Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
Tricoci P, Harrington RA, Valgimigli M. Tricoci P, et al. Among authors: valgimigli m. Circulation. 2005 Oct 25;112(17):e282; author reply e283. doi: 10.1161/CIRCULATIONAHA.105.568139. Circulation. 2005. PMID: 16246954 No abstract available.
780 results